+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Progressive supranuclear palsy and corticobasal degeneration



Progressive supranuclear palsy and corticobasal degeneration



Bailliere's Clinical Neurology 6(1): 167-185



The clinical and neuropathological features characteristic of progressive supranuclear palsy and corticobasal degeneration are described in detail. These disorders are not as rare as previously believed, but are poorly recognized. In patients with parkinsonism, a high index of clinical suspicion, sometimes complemented by specific laboratory tests, should improve diagnostic accuracy. Biological treatments are at present not available, but suggested symptomatic therapies may improve the quality of life of patients with these disorders.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047096609

Download citation: RISBibTeXText

PMID: 9426874


Related references

Corticobasal degeneration: widespread argentophilic threads and glia in addition to neurofibrillary tangles. Similarities of cytoskeletal abnormalities in corticobasal degeneration and progressive supranuclear palsy. Journal of the Neurological Sciences 138(1-2): 66-77, 1996

Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. Journal of Neuropathology and Experimental Neurology 60(6): 647-657, 2001

Similarities and differences among progressive among progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Neuropathology 16(4): 262-268, 1996

Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively exon 10 isoforms. Journal of Neurochemistry 72(3): 1243-1249, 1999

Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy. International Review of Psychiatry 25(2): 197-209, 2013

Treatment of progressive supranuclear palsy and corticobasal degeneration. Movement Disorders 20(Suppl. 12): S83-S91, 2005

Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Disease and Associated Disorders 21(4): S31-S38, 2007

Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. Journal of Neurology 247(5): 356-363, 2000

Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24(1): 79-86, 2004

Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. Journal of Neurocytology 33(3): 287-295, 2004

Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 64(3): 448-453, 2005

Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 34(6): 555-570, 2014

Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No. Movement Disorders Clinical Practice 5(2): 141-144, 2018

Neuropsychological comparison between corticobasal degeneration and progressive supranuclear palsy. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 37(7): 541-547, 2000

Key emerging issues in progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology 262(3): 783-788, 2015